These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 16967462

  • 21. The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status, volume of resection, and pathologist workload.
    Rizzo M, Iyengar R, Gabram SG, Park J, Birdsong G, Chandler KL, Mosunjac MB.
    Ann Surg Oncol; 2010 Jan; 17(1):228-34. PubMed ID: 19636625
    [Abstract] [Full Text] [Related]

  • 22. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F.
    Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
    [Abstract] [Full Text] [Related]

  • 23. Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
    Parikh RR, Housman D, Yang Q, Toppmeyer D, Wilson LD, Haffty BG.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1056-63. PubMed ID: 18676094
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Early ipsilateral breast tumor recurrences after breast conservation affect survival: an analysis of the National Cancer Institute randomized trial.
    Brooks JP, Danforth DN, Albert P, Sciuto LC, Smith SL, Camphausen KA, Poggi MM.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):785-9. PubMed ID: 15936560
    [Abstract] [Full Text] [Related]

  • 26. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.
    Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE, Jeong JH, Tan-Chiu E, Fisher B, Wolmark N.
    J Clin Oncol; 2006 May 01; 24(13):2028-37. PubMed ID: 16648502
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Breast conservation in patients with multiple ipsilateral synchronous cancers.
    Kaplan J, Giron G, Tartter PI, Bleiweiss IJ, Estabrook A, Smith SR.
    J Am Coll Surg; 2003 Nov 01; 197(5):726-9. PubMed ID: 14585405
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
    Mechera R, Viehl CT, Oertli D.
    Breast Cancer Res Treat; 2009 Jul 01; 116(1):171-7. PubMed ID: 18815880
    [Abstract] [Full Text] [Related]

  • 32. Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.
    Massidda B, Atzori F, Scanu A, Contu A, Farris A, Catino AM, Palmeri S, Minerba L, Ionta MT.
    Oncology; 2007 Jul 01; 72(1-2):17-26. PubMed ID: 17998786
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM, GEICAM 9906 Study Investigators.
    J Natl Cancer Inst; 2008 Jun 04; 100(11):805-14. PubMed ID: 18505968
    [Abstract] [Full Text] [Related]

  • 36. Can we predict local recurrence in breast conserving surgery after neoadjuvant chemotherapy?
    Cebrecos I, Córdoba O, Deu J, Xercavins J, Rubio IT.
    Eur J Surg Oncol; 2010 Jun 04; 36(6):528-34. PubMed ID: 20444571
    [Abstract] [Full Text] [Related]

  • 37. Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy.
    Balch GC, Mithani SK, Simpson JF, Kelley MC.
    Am Surg; 2005 Jan 04; 71(1):22-7; discussion 27-8. PubMed ID: 15757052
    [Abstract] [Full Text] [Related]

  • 38. Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
    Han S, Kim J, Sohn S, Kwak GH, Kim JY, Park K.
    J Surg Oncol; 2007 Jan 01; 95(1):45-50. PubMed ID: 17192866
    [Abstract] [Full Text] [Related]

  • 39. Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast.
    Schwartz GF, Meltzer AJ, Lucarelli EA, Cantor JP, Curcillo PG.
    J Am Coll Surg; 2005 Sep 01; 201(3):327-34. PubMed ID: 16125064
    [Abstract] [Full Text] [Related]

  • 40. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D, Lackenbauer A, Wulf J, Guckenberger M, Flentje M.
    Oncol Rep; 2007 Nov 01; 18(5):1335-9. PubMed ID: 17914594
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.